GTCM
ZBH icon

Gyon Technologies Capital Management’s Zimmer Biomet ZBH Stock Holding History

Gyon Technologies Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,323
Closed -$330K – 666
2021
Q3 		$330K Buy
+2,323
New +$342K 0.09% 274
2021
Q2 		– Sell
-1,406
Closed -$219K – 510
2021
Q1 		$219K Sell
1,406
-3,580
-72% -$555K 0.1% 363
2020
Q4 		$746K Buy
+4,986
New +$704K 0.26% 121

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Gyon Technologies Capital Management's ZBH Position: Q4 2021 in Review

Gyon Technologies Capital Management sold out of Zimmer Biomet (ZBH) in Q4 2021, closing a stake of 2,323 shares — an estimated $330K sold.

Gyon Technologies Capital Management first reported a position in ZBH in Q4 2020 and held it in 3 quarters. The position peaked at $746K in Q4 2020. 998 funds tracked by Wall St. Rank hold ZBH as of Q4 2021.

  • Gyon Technologies Capital Management reported no remaining Zimmer Biomet position as of Q4 2021 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 2,323 Zimmer Biomet shares in Q4 2021, an estimated $330K.
  • Gyon Technologies Capital Management first reported a position in Zimmer Biomet in Q4 2020 and held it in 3 quarters.
  • Gyon Technologies Capital Management's Zimmer Biomet position peaked at $746K in Q4 2020.
  • 998 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2021.

Based on Gyon Technologies Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.